ERT, has announced its pre-conference workshop to be co-hosted with Healthcare Technology Systems.
ERT is provider of Epro, centralised ECG and other services to the biopharmaceutical, medical device and related industries.
As part of the Clinical Trials in CNS conference, the workshop, entitled 'Assessing Suicidality in Clinical Trials and Addressing the Regulatory Directives', will be held at 1:30-4:30pm on Tuesday 24 November 2009, in London, UK.
The workshop is designed to guide clinical directors, therapy heads, medical directors and clinical project managers through FDA regulatory directives so that they will be better informed and prepared for future trial planning.
During the workshop, three professionals will present methods to ensure that participants' safety monitoring meets the standards and assessments needed in all clinical studies.
The guest speakers include Alan Gelenberg, managing director, president and chief executive officer of Healthcare Technology Systems and Public Health and editor-in-chief of the Journal of Clinical Psychiatry; Michael Federico, vice president of Epro; and Peter Bennett, product specialist of Epro, ERT.
In conjunction with R+D Directions, ERT will also be hosting a webinar on September 17 2009, titled 'Investigator Site Solutions for Clinical Trials'.
The hour-long event will examine data solutions that investigators can use to gather, monitor and disseminate data from clinical trials.
ERT will examine a monitoring and alerting system for tracking suicidality in clinical trials through computerised automation.
